Close
Risk of death – clinical trial statistics explained

Risk of death – clinical trial statistics explained

Reading Time: 5 minutes "New drug reduces risk of death by 50%"

You may have seen this type of headline in news articles reporting on the outcome of clinical trials. Reading this headline can lead people to believe a potential drug is highly beneficial and has a real impact. However, it is important to delve a little deeper into the meaning of ‘risk of death’, the raw data behind it, and how it should be considered alongside other outcome measures of a trial to fully determine how effective a drug might be.

The challenges of MND clinical trials

The challenges of MND clinical trials

Reading Time: 6 minutes On the 8 September 2023, members of the Research Development team at the MND Association attended the 4th UCL Queen Square Motor Neuron Disease Centre International Symposium. Leading international researchers were invited to speak about key areas of MND research, with a focus on translational research. We listened to talks on early laboratory research and…